COURSE DIRECTOR
David Dingli, MD and Andrew Bentall, M.B., Ch.B., M.D.

DESCRIPTION
Solid organ and stem cell transplant are complex therapeutic approaches and require a deep understanding of immunology, specific therapeutics, expertise in the care of post-transplant complications and patient support. The aim of the Transplant Core curriculum is to provide in a didactic format the broad education that is needed to ensure that the transplant physicians, surgeons, pharmacists, and nurses are able to safely care for such patients.

TARGET AUDIENCE
Transplant Core Curriculum are attended by a broad audience including physicians, surgeons, nurses, nurse practitioners, physician assistants, technologists, research and support personnel with a wide variety of backgrounds that share in the care of patients undergoing transplantation. 

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Develop core competencies in the care of patients undergoing or after transplantation.
• Demonstrate how to share good and bad news with patients and their families.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification - American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

ACPE

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 0.50 ACPE knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.  Each module offers 0.50 ACPE knowledge-based contact hours.

Pharmacy CE credit is electronically transferred to the National Association of Boards of Pharmacy CPE Monitor. To track CE, please visit NABP CPE Monitor. 

UAN Number:  JA0000238-0000-24-012-L01-P

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
David Dingli, MD - Intellectual Property - Houston Pharma, Inc., Imanis Life Sciences, LLC, NISCO Honoraria -  Novartis, 21GRAMS, Janssen Biotech, Inc.,  Alexion Pharmaceuticals, Inc., Advarra, Novartis Pharmaceuticals Corporation, Ossium Health, Inc, UCB Pharma GmbH, Immunome Inc., Apellis Pharmaceuticals, Legend Biotech USA Inc., Genzyme Corporation, Second City Science, DAVA Oncology, LP, Argenx US Inc., Sanofi Genzyme, Curio Science LLC, Janssen Scientific Affairs, LLC, Merck Sharp & Dohme Corp., Takeda Pharmaceuticals, Inc., Takeda           

Andrew J. Bentall, M.B., Ch.B., M.D. - Consultant - Talaris Therapeutics and Genome British Columbia (added 2/29/2024)

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Michelle Bumgardner, MSN, RN, Rachel E. Huntsman, Pharm.D., R.Ph., Stephanie Putzier

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Stephanie Putzier, Department Coordinator, at ph. 6-8731.